基于多源数据的公交车能耗碳排放测算模型

公交车能耗碳排放强度与车辆、线路和驾驶员有显著相关关系，为精准刻画其能耗碳排放强度特征，整合OBD监测数据、加油(气)数据、运营排班数据等多源数据资源. OBD监测数据和加油(气)数据呈显著的线性关系，证明修正后的OBD监测数据可满足分析要求. 搭建“速度-能耗碳排放强度曲线”测算模型，幂函数关系的拟合优度R2 =0.972 6 为最高. 实证研究发现，平均速度在10~60 km/h 变化时，液化天然气(LNG)车比柴油车能耗碳排放强度高 3.3%~33.7%，双层车比铰接车高2.4%~13.3%；LNG铰接车在不同线路、相同速度下的强度相差9.6%；不同驾驶员在相同线路的能耗碳排放强度可相差24.2%. 模型为各城市基于多源数据开展公交能耗碳排放目标设定提供数据支撑.     

Validating and improving public transport origin–destination estimation algorithm using smart card fare data

Smart card data are increasingly used for transit network planning, passengers’ behaviour analysis and network demand forecasting. Public transport origin–destination (O–D) estimation is a significant product of processing smart card data. In recent years, various O–D estimation methods using the trip-chaining approach have attracted much attention from both researchers and practitioners. However, the validity of these estimation methods has not been extensively investigated. This is mainly because these datasets usually lack data about passengers’ alighting, as passengers are often required to tap their smart cards only when boarding a public transport service. Thus, this paper has two main objectives. First, the paper reports on the implementation and validation of the existing O–D estimation method using the unique smart card dataset of the South-East Queensland public transport network which includes data on both boarding stops and alighting stops. Second, the paper improves the O–D estimation algorithm and empirically examines these improvements, relying on this unique dataset. The evaluation of the last destination assumption of the trip-chaining method shows a significant negative impact on the matching results of the differences between actual boarding/alighting times and the public transport schedules. The proposed changes to the algorithm improve the average distance between the actual and estimated alighting stops, as this distance is reduced from 806 m using the original algorithm to 530 m after applying the suggested improvements.     

浅埋顶管沉井周边土体的三维破坏形状及沉降研究

为研究顶管沉井及周边土体在顶进力作用下的形变范围与大小，以加固旋喷桩作为沉井周围加固体建立ABAQUS软件计算模型，并将模拟结果与工程实例、PLAXIS 3D软件所得结果进行对比分析。同时，采用广州地区花岗岩残积土进行室内沉井模型试验，并通过试验结果对数值模拟结论进行验证，得出结论如下： 1）在开挖基坑前达到设计强度的旋喷桩能有效减小基坑周边土体塌陷变形、坑底隆起。2）在施加工作顶推力下，前侧主动区首先出现贯通裂缝，竖向位移斜率增大出现明显拐点；继续增大顶推力，土体位移会急剧增大导致地表沉降严重。3）对于后背土体，在顶推力作用下，地表破裂线的切线角度从0°逐渐增大至45°+φ/2，导致破裂范围也不断扩大；达到45°+φ/2处后，继续施加顶推力会导致短轴方向破坏范围扩大的速度较长轴方向的速度更快；三维空间中被动区破坏土体在地表处产生形状为椭圆的破坏面，椭圆长轴方向为顶推轴线方向，被动破坏体呈现为牛角状椭圆楔体。     

Caterham Seven 420R v Porsche 911 GT3 RS

在赛道作为一条经验法则,除非420R在打滑,否则其实它根本没用尽全力。它会转向不足——其实有时还挺有用的,如果你非要找到它的极限并再用力推过头一点点的话;但如果你就是入弯时对前胎要求过高那它就那么有帮助了。Seven之妙处在于驾驶者可以立刻知道当前的情况。你完全可以在入弯到     

羟基喜树碱对人胆管癌QBC939裸鼠移植瘤PS2、COX-2的影响

目的探讨羟基喜树碱对人胆管癌QBC939裸鼠移植瘤的乳癌相关肽(PS2)、环氧合酶-2(COX-2)的影响,分析PS2、COX-2与肿瘤发生、发展的关系。方法建立人胆管癌QBC939细胞株裸鼠皮下移植瘤模型,将30只裸鼠随机分成对照组、羟基喜树碱低剂量组和羟基喜树碱高剂量组,观察移植瘤体生长情况,RT-PCR法检测瘤体内PS2、COX-2 mRNA表达。结果与对照组比,羟基喜树碱低、高剂量组都可使移植瘤体的PS2 mRNA表达增高;COX-2 mRNA表达降低,且瘤体生长减慢,与对照组比较差异有统计学意义(P<0.01)。结论羟基喜树碱可降低移植瘤COX-2 mRNA表达,增高移植瘤体的PS2 mRNA表达,并使人胆管癌裸鼠移植瘤生长减慢。     

VEGF-C、VEGFR-3和podoplanin在食管癌中的表达及其意义

目的观察血管内皮生长因子C(VEGF-C)及其受体3(VEGFR-3)和肾小球上皮细胞整合膜蛋白(podoplanin)在食管癌组织中的表达,分析其与肿瘤淋巴结转移的关系。方法免疫组织化学SP法检测76例食管癌组织中VEGF-C、VEGFR-3和podoplanin的表达及淋巴管密度(LVD)。结果食管癌VEGF-C表达阳性率为63.1%,VEGF-C的表达与食管癌的淋巴结转移、TNM分期有统计学意义(P<0.01,P<0.05),但与患者年龄、肿瘤大小及分化程度无关;癌旁组织淋巴管密度同淋巴结转移、VEGF-C阳性表达间有统计学意义(P<0.01,P<0.05),podo-planin LVD值与VEGFR-3 LVD值相比,具有统计学意义(P<0.01)。结论食管癌组织中VEGF-C表达与肿瘤TNM分期、淋巴管密度和淋巴结转移有关,VEGF-C表达越高,淋巴管密度越大,淋巴结转移可能性越高。癌旁组织LVD同VEGF-C的高表达及淋巴结转移密切相关,食管癌组织中podoplanin标记的淋巴管密度较VEGFR-3标记的淋巴管密度更为精确,是一种更为满意的淋巴管内皮特异性标志物。     

Study on T lymphocyte subsets and NK cells in patients with Graves＇ disease combined with type 2 diabetes

Objective To investigate changes in T lymphocyte subsets and NK cells in patients with simple Graves' disease (GD)and Graves' disease combined with type 2 diabetes mellitus (GD/T2DM). Methods Fifteen cases of GD/ T2DM were selected from our hospital from November 2001 to November 2004. Before and after therapy thyroid function, thyroglobulin antibody (TGA), thyroid microsomal antibody (TMA) and blood glucose level were measured, and T lymphocyte subsets (CD3, CD4, CD8, CD4/CD8) and NK cells (CD56) were measured by immunofluorescence double labeling monoclonal antibody and flow cytometry, respectively. At the same time, comparison was made with simple GD (15 cases), T2DM (15 cases) and healthy control (20 cases). Results Before therapy, CD4/CD8, CD4 and NK cells in GD/T2DM were less than normal, and there was no significant difference in comparison with simple GD (P<0.05). In T2DM group, only CD4/CD8 and CD4 were less than those of healthy controls (P<0.05). When thyroid function recovered after 1 to 3 months of methimazole treatment in both GD/T2DM and simple GD groups, various indexes recovered, which were more obvious in simple GD. Conclusion Immune hypofunction of GD may be the key to the immune abnormality of GD/T2DM, which is more significant than that of simple GD or T2DM. The recovery of thyroid function and immune abnormality is not consistent, and the recovery of GD is more significant than that of GD/T2DM.     

健胃愈疡颗粒对慢性胃炎伴幽门螺杆菌感染胃黏膜PAF、PS2的表达及对上皮细胞凋亡的影响

目的观察健胃愈疡颗粒(JWYY)对幽门螺杆菌相关性胃炎胃黏膜乳癌相关肽(PS2)和血小板活化因子(plate-let activating factor,PAF)表达的变化,并分析其可能的作用机制。方法80例幽门螺杆菌感染慢性胃炎患者随机分为2组,治疗组42例给予健胃愈疡颗粒治疗,对照组38例给予西药三联药物治疗。应用胃镜下活检胃黏膜组织快速尿素酶和Warthin-Starry染色法检测幽门螺杆菌,应用Western blot检测PS2、PAF表达变化。应用末端转移酶介导的dUTP切口末段标记法(TUNEL)检测细胞凋亡。第4周复查胃镜。结果治疗组凋亡指数明显比对照组减少(P<0.05),治疗组总有效率高于对照组(P<0.05)。Western blot检测显示:JWYY颗粒可上调PS2并下调PAF的表达,而对照组对胃黏膜PS2和PAF的表达影响不大。结论健胃愈疡颗粒治疗幽门螺杆菌(Hp)相关性胃炎可能与杀灭Hp、上调PS2和下调PAF的表达来抑制细胞凋亡有关。     

2型糖尿病患者一级亲属正常糖代谢人群胰岛素抵抗分析

目的探讨2型糖尿病(T2DM)患者糖耐量正常的一级亲属胰岛β细胞功能及胰岛素抵抗情况,并分析胰岛素抵抗的相关因素。方法选取T2DM患者糖耐量正常的一级亲属63例,根据胰岛素抵抗指数分为胰岛素抵抗组及非抵抗组;选取30例健康体检者作为正常对照组。对所选的93例对象进行血压、血糖、胰岛素、血脂的测定,并计算稳态模型胰岛素抵抗指数(HOMA-IR)及胰岛β细胞功能指数(HOMA-β)。结果①糖尿病患者一级亲属组与对照组相比,胰岛素水平、HOMA-IR、HOMA-β明显升高(P<0.05);②胰岛素抵抗组体质指数、舒张压、甘油三酯、餐后血糖、HOMA-β明显高于胰岛素非抵抗组(P<0.05);③相关分析示胰岛素抵抗与体质指数、舒张压、甘油三酯、餐后胰岛素呈正相关(P<0.01,P<0.05),与空腹血糖、餐后血糖、空腹胰岛素、收缩压、胆固醇无显著相关性(P>0.05)。结论T2DM患者一级亲属存在胰岛β细胞代偿性的高分泌,早期已经出现胰岛素敏感性的下降和胰岛素抵抗。胰岛素抵抗与体重增加、舒张压升高及甘油三酯的升高有关。提示对糖尿病患者一级亲属应严格控制体重、血压及血脂,对减少T2DM具有积极意义。